Getting help for depression and anxiety has significant long-term benefits

Oct 01, 2008

University of Alberta researcher Ian Colman and his team performed a study to see the long term effects of taking antidepressants or anti-anxiety medications.They found people who were not using antidepressants or anti-anxiety medications were three times more likely to be suffering from depression or anxiety 10 years later.

According to the Mood Disorder Society of Canada, about 1.3 million Canadians suffer from depression.

University of Alberta researcher Ian Colman says most people are not getting the type of treatment they need.

Colman, an assistant professor from the School of Public Health, and his research team decided to perform a study to see the long term effects of taking antidepressants or anti-anxiety medications.

The team studied a group of 200 people who were diagnosed with either depression or anxiety. Of that group, 45 were on medication.

The group of 200 had their mental health assessed in 1989 through a series of questions in a survey asking about their illness and what, if any, treatments they were on. Ten years later the group took a similar questionnaire.

Colman says they were surprised to find those who were not using antidepressants or anti-anxiety medications were three times more likely to be suffering from depression or anxiety 10 years later.

"This is a significant find," said Colman. "What this tells us is that, if people get treated initially, they are less likely to have a relapse in the future. This could be a significant benefit, not only for the patient but also for the health-care system as it's estimated the economic costs in Canada associated with depression are $14 billion per year."

Colman says depression and anxiety have a stigma attached to them and that people are often afraid to admit they have a mental disorder. But he hopes this new information will help people realize the long-term benefits of getting help right away.

Source: University of Alberta

Explore further: New hope for rare disease drug development

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New hope for rare disease drug development

3 hours ago

Using combinations of well-known approved drugs has for the first time been shown to be potentially safe in treating a rare disease, according to the results of a clinical trial published in the open access Orphanet Journal of ...

Three weeks since last Ebola case in Mali: WHO

6 hours ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

Migraine may double risk for facial paralysis

6 hours ago

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology, the medical journa ...

Anti-diabetic drug springs new hope for tuberculosis patients

13 hours ago

A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

menkaur
not rated yet Oct 02, 2008
is it better then if they were in a normal therapy?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.